ArticleCancers2022
Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma.
Jesper Geert Pedersen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled ittrialcites it
ArticleCancers2022
Jesper Geert Pedersen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.